•
Sep 30, 2018

Corcept Therapeutics Q3 2018 Earnings Report

Total Revenue
$64.4M
Previous year: $42.8M
+50.7%
EPS
$0.22
Previous year: $0.14
+57.1%
Gross Profit
$63.1M
Previous year: $41.8M
+51.1%
Cash and Equivalents
$33.9M
Previous year: $31.1M
+9.1%
Free Cash Flow
$44.5M
Previous year: $10.8M
+310.0%
Total Assets
$300M
Previous year: $111M
+170.8%

Corcept Therapeutics

Corcept Therapeutics